Abstract 232 Table 1
Endpoints
Early BNR
(n=23)
Late BNR
(n=10)
P-Value
Subsequent 5 Year Survival
87.0%
50.0%
0.020
Subsequent 5 Year Freedom from CAV
82.6%
40.0%
<0.001
Subsequent 5 Year Freedom from NF-MACE
47.8%
30.0%
0.369